Used as a chiral iridium-based catalyst in asymmetric synthesis, particularly in enantioselective hydrogenation reactions. It enables high enantioselectivity in the reduction of prochiral olefins and imines, making it valuable in the production of optically active pharmaceuticals and fine chemicals. The ligand environment enhances stereocontrol, allowing efficient synthesis of single-enantiomer compounds. Commonly applied in academic and industrial research for developing asymmetric catalytic processes.